Cargando…

T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis()

BACKGROUND: In the Investigation of the Management of Pericarditis (IMPI) randomized control, 2x2 factorial trial, Mycobacterium indicus pranii (MIP) immunotherapy, adjunctive corticosteroids or MIP combined with corticosteroids was compared to standard tuberculosis (TB) therapy for tuberculous peri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steigler, Pia, Chhiba, Mukesh, Francis, Veronica, Keyser, Alana, Abrahams, Deborah, Hanekom, Willem, Ntsekhe, Mpiko, Scriba, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218164/ https://www.ncbi.nlm.nih.gov/pubmed/35755143 http://dx.doi.org/10.1016/j.jvacx.2022.100177

Ejemplares similares

Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis
por: Faujdar, Jaya, et al.
Publicado: (2011)

“Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare
por: Alexander, David C., et al.
Publicado: (2015)

Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
por: Gupta, Ankan, et al.
Publicado: (2012)

Diagnosis and Management of Tuberculous Pericarditis: What Is New?
por: Isiguzo, Godsent, et al.
Publicado: (2020)

The importance of perseverance, pilot studies and the search for effective adjuvant therapies in the management of tuberculous pericarditis
por: Mutyaba, Arthur, et al.
Publicado: (2016)

Interventions for treating tuberculous pericarditis
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
por: Sharma, Surendra K., et al.
Publicado: (2017)

Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct Species
por: Saini, Vikram, et al.
Publicado: (2009)

Massive gene acquisitions in Mycobacterium indicus pranii provide a perspective on mycobacterial evolution
por: Saini, Vikram, et al.
Publicado: (2012)

Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages
por: Singh, Bindu, et al.
Publicado: (2019)

Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality
por: Pasipanodya, Jotam G., et al.
Publicado: (2015)

Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study
por: Shenje, Justin, et al.
Publicado: (2019)

Mycobacterium indicus pranii Supernatant Induces Apoptotic Cell Death in Mouse Peritoneal Macrophages In Vitro
por: Pandey, Rajeev Kumar, et al.
Publicado: (2011)

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine()
por: Gupta, Sunil Kumar, et al.
Publicado: (2022)

Reply to ‘“Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare’: “M. indicus pranii” Is a Distinct Strain, Not Derived from M. intracellulare, and Is an Organism at an Evolutionary Transition Point between a Fast Grower and Slow Grower
por: Rahman, S. A., et al.
Publicado: (2015)

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016)

Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii
por: Roy, Gargi, et al.
Publicado: (2023)

Persistent Exaggerated Granulomatous Hypersensitivity Reaction to Mycobacterium indicus pranii Immunomodulatory Therapy for COVID-19 Sepsis
por: Mehta, Nikhil, et al.
Publicado: (2023)

Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages
por: Singh, Bindu, et al.
Publicado: (2017)

HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study
por: Ntsekhe, Mpiko, et al.
Publicado: (2008)

Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell lines
por: Subramaniam, Menaga, et al.
Publicado: (2016)

Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner
por: Kumar, Pawan, et al.
Publicado: (2019)

Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion
por: Ntsekhe, Mpiko, et al.
Publicado: (2013)

Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection
por: Gupta, Ananya, et al.
Publicado: (2019)

Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice
por: Ahmad, Faiz, et al.
Publicado: (2011)

Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis
por: Ramasamy, Vinasha, et al.
Publicado: (2018)

Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of “Mycobacterium indicus pranii” genotypes in human lung infection
por: Kim, Su-Young, et al.
Publicado: (2015)

The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature
por: Ntsekhe, Mpiko, et al.
Publicado: (2012)

Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study
por: Ntsekhe, Mpiko, et al.
Publicado: (2012)

Mycobacterium indicus pranii (Mw) Re-Establishes Host Protective Immune Response in Leishmania donovani Infected Macrophages: Critical Role of IL-12
por: Adhikari, Anupam, et al.
Publicado: (2012)

Tuberculous Pericarditis
por: Semple, Thomas
Publicado: (1948)

Tuberculous Pericarditis
por: Singh, Balbir
Publicado: (1949)

Tuberculous pericarditis
por: Jurado, Leonardo F., et al.
Publicado: (2020)

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study
por: Pandie, Shaheen, et al.
Publicado: (2014)

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry
por: Mayosi, Bongani M, et al.
Publicado: (2006)

Tuberculous Constrictive Pericarditis
por: Tse, Gary, et al.
Publicado: (2015)

Tuberculous Pericarditis in the Senile
Publicado: (1931)

HIV-1 infection alters CD4(+) memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis
por: Matthews, Kerryn, et al.
Publicado: (2012)

Cardiovascular magnetic resonance characterisation of pericardial and myocardial involvement in patients with tuberculous pericardial constriction with and without HIV co-infection
por: Ntusi, Ntobeko A, et al.
Publicado: (2016)

Tuberculous Pericarditis as a Sole Tuberculous Lesion in an Old Man
por: Alston, J. M.
Publicado: (1928)

Cannot write session to /tmp/vufind_sessions/sess_s7995k1tgqq2fegi1c7n2m1hgt